|
Previous: ORTHALLIANCE INC, SC 13G/A, 2000-02-10 |
Next: UNDERWRITERS RE GROUP INC, 13F-NT, 2000-02-10 |
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
[X] | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 31, 1999
[ ] | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT |
For the transition period from to
Commission file number 333-28157
TEKNI-PLEX, INC.
Delaware (State or other jurisdiction of incorporation or organization) |
22-3286312 (IRS Employer Identification Number) |
|
201 Industrial Parkway Somerville, New Jersey (Address of principal executive office) |
08876 (Zip Code) |
(908) 722-4800
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
[X] Yes [ ] No
TEKNI-PLEX, INC.
Page # | |||||||
PART I. FINANCIAL INFORMATION | |||||||
Item 1. | Financial Statements | ||||||
Consolidated Balance Sheets as of December 31, 1999 and July 2, 1999 | 3 | ||||||
Consolidated Statements of Operations for the six months and three months ended December 31, 1999 and January 1, 1999 | 4 | ||||||
Consolidated Statements of Comprehensive Income for the six months and three months ended December 31, 1999 and January 1, 1999 | 4 | ||||||
Consolidated Statements of Cash Flows for the six months ended December 31, 1999 and January 1, 1999 | 5 | ||||||
Notes to Consolidated Financial Statements | 6-11 | ||||||
Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations | 12-14 | |||||
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 14 | |||||
PART II. OTHER INFORMATION | |||||||
Item 1. | Legal proceedings | 15 | |||||
Item 2. | Changes in securities | 15 | |||||
Item 3. | Defaults upon senior securities | 15 | |||||
Item 4. | Submission of matters to a vote of securities holders | 15 | |||||
Item 5. | Other information | 15 | |||||
Item 6. | Exhibits and reports on Form 8-K | 15 |
TEKNI-PLEX, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
December 31, | July 2, | |||||||||
1999 | 1999 | |||||||||
(Unaudited) | ||||||||||
ASSETS | ||||||||||
Current: | ||||||||||
Cash | $ | 23,345 | $ | 22,117 | ||||||
Accounts receivable, net of an allowance of $1,574 and $1,662 for possible losses | 60,253 | 96,835 | ||||||||
Inventories | 90,251 | 63,190 | ||||||||
Deferred income taxes | 5,700 | 5,900 | ||||||||
Prepaid expenses and other current assets | 9,492 | 3,664 | ||||||||
Total current assets | 189,041 | 191,706 | ||||||||
Property, plant and equipment, net | 132,498 | 136,953 | ||||||||
Intangible assets, net of accumulated amortization of $37,600 and $29,581 | 200,945 | 206,140 | ||||||||
Deferred financing costs, net of accumulated amortization of $5,556 and $4,287 | 18,112 | 19,358 | ||||||||
Deferred income taxes | 1,054 | 1,346 | ||||||||
Other assets | 4,070 | 3,933 | ||||||||
$ | 545,720 | $ | 559,436 | |||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||
Current liabilities: | ||||||||||
Current portion of long-term debt | $ | 6,173 | $ | 5,207 | ||||||
Line of credit | 456 | 541 | ||||||||
Accounts payable trade | 28,808 | 27,612 | ||||||||
Accrued payroll and benefits | 11,192 | 21,581 | ||||||||
Accrued interest | 9,099 | 7,965 | ||||||||
Accrued liabilities other | 19,418 | 26,613 | ||||||||
Income taxes payable | 156 | 742 | ||||||||
Total current liabilities | 75,302 | 90,261 | ||||||||
Long-term debt | 411,474 | 410,646 | ||||||||
Other liabilities | 4,900 | 6,232 | ||||||||
Total liabilities | 491,676 | 507,139 | ||||||||
Stockholders equity: | ||||||||||
Common stock | | | ||||||||
Additional paid-in capital | 41,075 | 41,075 | ||||||||
Cumulative currency translation adjustment | (3,373 | ) | (1,368 | ) | ||||||
Retained earnings | 16,342 | 12,590 | ||||||||
Total stockholders equity | 54,044 | 52,297 | ||||||||
$ | 545,720 | $ | 559,436 | |||||||
See accompanying notes to consolidated financial statements.
3
TEKNI-PLEX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended | Six Months Ended | |||||||||||||||||
December 31, | January 1, | December 31, | January 1, | |||||||||||||||
1999 | 1999 | 1999 | 1999 | |||||||||||||||
Net sales | $ | 102,381 | $ | 94,004 | $ | 212,307 | $ | 202,073 | ||||||||||
Cost of sales | 74,883 | 69,126 | 155,804 | 150,104 | ||||||||||||||
Gross profit | 27,498 | 24,878 | 56,503 | 51,969 | ||||||||||||||
Operating expenses: | ||||||||||||||||||
Selling, general and administrative | 14,846 | 14,558 | 28,988 | 28,518 | ||||||||||||||
Income from Operations | 12,652 | 10,320 | 27,515 | 23,451 | ||||||||||||||
Other expenses: | ||||||||||||||||||
Interest, net | 9,914 | 9,399 | 19,539 | 19,006 | ||||||||||||||
Other | 441 | 122 | 623 | 497 | ||||||||||||||
Income before provision for income taxes | 2,297 | 799 | 7,353 | 3,948 | ||||||||||||||
Provision for income taxes | 1,100 | 294 | 3,600 | 1,900 | ||||||||||||||
Net income | $ | 1,197 | $ | 505 | $ | 3,753 | $ | 2,048 | ||||||||||
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||||||||||||||||
Net income | $ | 1,197 | $ | 505 | $ | 3,753 | $ | 2,048 | ||||||||||
Other comprehensive income (loss), net of taxes | ||||||||||||||||||
Foreign currency translation adjustment | (1,362 | ) | (495 | ) | (2,005 | ) | 1,076 | |||||||||||
Comprehensive income (loss) | $ | (165 | ) | $ | 10 | $ | 1,748 | $ | 3,124 | |||||||||
See accompanying notes to consolidated financial statements.
4
TEKNI-PLEX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended | |||||||||||
December 31, | January | ||||||||||
1999 | 1, 1999 | ||||||||||
Cash flows from Operating Activities: | |||||||||||
Net income | $ | 3,753 | $ | 2,048 | |||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |||||||||||
Depreciation and amortization | 16,712 | 16,294 | |||||||||
Deferred income taxes | 478 | | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 36,499 | 35,301 | |||||||||
Inventories | (27,168 | ) | (21,617 | ) | |||||||
Prepaid expenses and other current assets | (5,960 | ) | (593 | ) | |||||||
Income taxes | (486 | ) | (2,436 | ) | |||||||
Accounts payable | 912 | (5,649 | ) | ||||||||
Accrued interest | 1,102 | 332 | |||||||||
Accrued expenses and other liabilities | (19,556 | ) | (17,879 | ) | |||||||
Net cash provided by Operating Activities | 6,286 | 5,801 | |||||||||
Cash flows from Investing Activities: | |||||||||||
Capital expenditures | (6,212 | ) | (4,838 | ) | |||||||
Acquisition costs | (144 | ) | (88 | ) | |||||||
Deposits and other assets | (145 | ) | 1,924 | ||||||||
Net cash used in Investing Activities | (6,501 | ) | (3,002 | ) | |||||||
Cash flows from Financing Activities: | |||||||||||
Borrowings (repayments) of long-term debt | 1,551 | (4,261 | ) | ||||||||
Net borrowings (repayments) under line of credit | (85 | ) | 54 | ||||||||
Debt financing costs | (23 | ) | | ||||||||
Net cash provided by (used in) Financing Activities | 1,443 | (4,207 | ) | ||||||||
Net increase (decrease) in Cash | 1,228 | (1,408 | ) | ||||||||
Cash, beginning of period | 22,117 | 29,363 | |||||||||
Cash, end of period | $ | 23,345 | $ | 27,955 | |||||||
Supplemental cash flow information: | |||||||||||
Cash paid for: | |||||||||||
Interest | $ | 19,978 | $ | 18,580 | |||||||
Income taxes | 5,139 | 5,822 | |||||||||
See accompanying notes to consolidated financial statements.
5
TEKNI-PLEX, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1 General
Tekni-Plex is a global, diversified manufacturer of packaging, products, and materials for the healthcare, consumer, and food packaging industries. The Company has built a leadership position in its core markets, and focuses on vertically integrated production of highly specialized products. The Companys operations are aligned under four primary business groups: Healthcare Packaging, Products, and Materials; Consumer Packaging and Products; Food Packaging; and Specialty Resins and Compounds.
In the opinion of management, all adjustments considered necessary for a fair presentation have been included. For further information please refer to the audited financial statements and footnotes thereto included in the Companys Annual Report on Form 10-K for the year ended July 2, 1999.
Note 2 Inventories
Inventories as of December 31, 1999 and July 2, 1999 are summarized as follows:
December 31, | July 2, | |||||||
1999 | 1999 | |||||||
Raw materials | $ | 29,763 | $ | 26,663 | ||||
Work-in-process | 6,414 | 5,282 | ||||||
Finished goods | 54,074 | 31,245 | ||||||
$ | 90,251 | $ | 63,190 | |||||
Note 3 Long-Term Debt
Long-term debt consists of the following:
December 31, | July 2, | ||||||||
1999 | 1999 | ||||||||
Senior Subordinated Notes issued March 3, 1998 at 9 1/4% due March 1, 2008 | $ | 200,000 | $ | 200,000 | |||||
Senior Subordinated Notes issued April 4, 1997 at 11 1/4% due April 1, 2007 | 75,000 | 75,000 | |||||||
Senior Debt: | |||||||||
Revolving line of credit, expiring March 31, 2004. At December 31, 1999, the interest rate was 9.25% | 26,000 | 22,000 | |||||||
Term notes due March 31, 2004 and March 31, 2006, with interest rates at December 31, 1999 of 7.5625% and 8.0625% | 109,488 | 111,063 | |||||||
Other, primarily foreign term loans, with interest rates ranging from 4 1/4% to 8.4% and maturities from 2000 to 2004 | 7,615 | 8,331 | |||||||
418,103 | 416,394 | ||||||||
Less: Current maturities | 6,629 | 5,748 | |||||||
$ | 411,474 | $ | 410,646 | ||||||
Note 4 Contingencies
(a) | In January 1993 and 1994, the Companys Belgian subsidiary received income tax assessments aggregating approximately $1,874 (75,247 Belgian Francs) for the disallowance of certain foreign tax credits and investment losses claimed for the years ended July 31, 1990 and 1991. |
6
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Additionally, in January 1995, the subsidiary received an income tax assessment of approximately $799 (32,083 Belgian francs) for the year ended July 31, 1992. By Belgian law, these assessments are capped at the values above and do not continue to accrue additional penalties or interest. Although the future outcome of these matters is uncertain, the Company believes that its tax position was appropriate and that the assessments are without merit. Therefore, the Company has appealed the assessments. Based on advice of legal counsel in Belgium, the Company believes that the assessment appeals will be accepted by the tax authorities in Belgium, although there can be no assurance whether or when such appeals will be accepted. | ||
(b) | The Company is a party to various other legal proceedings arising in the normal conduct of business. Management believes that the final outcome of these proceedings will not have a material adverse effect on the Companys financial position. |
Note 5 Segment Information
The Company operates in four industry segments: healthcare packaging, products, and materials; consumer packaging and products; food packaging; and specialty resins and compounds. The healthcare packaging, products, and materials segment principally produces pharmaceutical packaging, medical tubing and medical device materials. The consumer packaging and products segment principally produces precision tubing and gaskets, and garden and irrigation hose products. The food packaging segment produces foamed polystyrene packaging products for the poultry, meat and egg industries. The specialty resins and compounds segment produces specialty PVC resins. The healthcare packaging, products, and materials and consumer packaging and products segments have operations in the United States, Europe and Canada. Prior to 1998, the Company operated principally in the food packaging segment.
Financial information concerning the Companys business segments and the geographic areas in which it operates are as follows:
Healthcare | ||||||||||||||||||||
Packaging, | Consumer | Specialty | ||||||||||||||||||
Products, | Packaging | Food | Resins and | |||||||||||||||||
and Materials | and Products | Packaging | Compounds | Total | ||||||||||||||||
Three months ended December 31, 1999 | ||||||||||||||||||||
Revenues from external customers | $ | 34,619 | $ | 28,376 | $ | 25,951 | $ | 13,435 | $ | 102,381 | ||||||||||
Interest expense | 2,974 | 3,319 | 2,122 | 1,499 | 9,914 | |||||||||||||||
Depreciation and amortization | 2,679 | 2,427 | 1,928 | 1,136 | 8,170 | |||||||||||||||
Income from operations | 5,396 | 4,472 | 6,900 | (370 | ) | 16,398 | ||||||||||||||
Expenditures for segment assets | 202 | 759 | 1,586 | 374 | 2,921 | |||||||||||||||
Three months ended January 1, 1999 | ||||||||||||||||||||
Revenues from external customers | $ | 28,666 | $ | 24,393 | $ | 24,422 | $ | 16,523 | $ | 94,004 | ||||||||||
Interest expense | 2,717 | 3,339 | 1,858 | 1,485 | 9,399 | |||||||||||||||
Depreciation and amortization | 1,819 | 4,302 | 875 | 1,261 | 8,257 | |||||||||||||||
Income from operations | 5,100 | 2,268 | 4,149 | 2,367 | 13,884 | |||||||||||||||
Expenditures for segment assets | 513 | 915 | 1,465 | 311 | 3,204 | |||||||||||||||
7
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Healthcare | ||||||||||||||||||||
Packaging, | Consumer | Specialty | ||||||||||||||||||
Products, | Packaging | Food | Resins and | |||||||||||||||||
and Materials | and Products | Packaging | Compounds | Total | ||||||||||||||||
Six months ended December 31, 1999 | ||||||||||||||||||||
Revenues from external customers | $ | 71,889 | $ | 60,802 | $ | 51,067 | $ | 28,549 | $ | 212,307 | ||||||||||
Interest expense | 5,831 | 6,531 | 4,223 | 2,954 | 19,539 | |||||||||||||||
Depreciation and amortization | 5,262 | 5,153 | 3,817 | 2,263 | 16,495 | |||||||||||||||
Income from operations | 12,498 | 8,985 | 11,573 | 1,099 | 34,155 | |||||||||||||||
Expenditures for segment assets | 1,081 | 1,663 | 2,764 | 554 | 6,062 | |||||||||||||||
Six months ended January 1, 1999 | ||||||||||||||||||||
Revenues from external customers | $ | 60,932 | $ | 56,841 | $ | 48,154 | $ | 36,146 | $ | 202,073 | ||||||||||
Interest expense | 5,495 | 6,752 | 3,757 | 3,002 | 19,006 | |||||||||||||||
Depreciation and amortization | 3,229 | 6,676 | 3,647 | 2,596 | 16,148 | |||||||||||||||
Income from operations | 10,381 | 8,455 | 6,940 | 4,277 | 30,053 | |||||||||||||||
Expenditures for segment assets | 1,086 | 1,241 | 2,055 | 382 | 4,764 | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||||
December 31, | January 1, | December 31, | January 1, | ||||||||||||||
1999 | 1999 | 1999 | 1999 | ||||||||||||||
Profit or Loss | |||||||||||||||||
Total operating profit for reportable segments before income taxes | $ | 16,398 | $ | 13,884 | $ | 34,155 | $ | 30,053 | |||||||||
Corporate and eliminations | (3,746 | ) | (3,564 | ) | (6,640 | ) | (6,602 | ) | |||||||||
$ | 12,652 | $ | 10,320 | $ | 27,515 | $ | 23,451 | ||||||||||
Depreciation and amortization | |||||||||||||||||
Segment totals | $ | 8,170 | $ | 8,257 | $ | 16,495 | $ | 16,148 | |||||||||
Corporate | 110 | (202 | ) | 217 | 146 | ||||||||||||
Consolidated total | $ | 8,280 | $ | 8,055 | $ | 16,712 | $ | 16,294 | |||||||||
Expenditures for Segment Assets | |||||||||||||||||
Total reportable-segment expenditures | $ | 2,921 | $ | 3,204 | $ | 6,062 | $ | 4,764 | |||||||||
Other unallocated expenditures | 101 | 56 | 150 | 74 | |||||||||||||
Consolidated total | $ | 3,022 | $ | 3,260 | $ | 6,212 | $ | 4,838 | |||||||||
8
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Segment assets
Healthcare | ||||||||||||||||||||
Packaging, | Consumer | Specialty | ||||||||||||||||||
Products, | Packaging | Food | Resins and | |||||||||||||||||
and Materials | and Products | Packaging | Compounds | Total | ||||||||||||||||
December 31, 1999 | 166,742 | 214,467 | 71,984 | 82,594 | 535,787 | |||||||||||||||
July 2, 1999 | 173,704 | 216,067 | 73,351 | 83,601 | 546,723 | |||||||||||||||
December 31, | July 2, | ||||||||
1999 | 1999 | ||||||||
Total Assets | |||||||||
Total assets from reportable segments | $ | 535,787 | $ | 546,723 | |||||
Other unallocated amounts | 9,933 | 12,713 | |||||||
Consolidated total | $ | 545,720 | $ | 559,436 | |||||
Geographic information
Three Months Ended | Six Months Ended | ||||||||||||||||
December 31, | January 1, | December 31, | January 1, | ||||||||||||||
1999 | 1999 | 1999 | 1999 | ||||||||||||||
Revenues | |||||||||||||||||
United States | $ | 91,904 | $ | 84,533 | $ | 191,943 | $ | 182,074 | |||||||||
International | 10,477 | 9,471 | 20,364 | 19,999 | |||||||||||||
Total | $ | 102,381 | $ | 94,004 | $ | 212,307 | $ | 202,073 | |||||||||
December 31, | July 2, | ||||||||
1999 | 1999 | ||||||||
Long-lived Assets | |||||||||
United States | $ | 329,004 | $ | 339,409 | |||||
International | 27,675 | 28,321 | |||||||
Total | $ | 356,679 | $ | 367,730 | |||||
9
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Note 6 Supplemental Condensed Consolidating Financial Statements
CONSOLIDATED STATEMENT OF EARNINGS
FOR THE THREE MONTHS ENDED DECEMBER 31, 1999
Non- | |||||||||||||||||
Total | Issuer | Guarantors | Guarantors | ||||||||||||||
Net sales | $ | 102,381 | $ | 32,045 | $ | 59,859 | $ | 10,477 | |||||||||
Cost of sales | 74,883 | 23,523 | 43,951 | 7,409 | |||||||||||||
Gross profit | 27,498 | 8,522 | 15,908 | 3,068 | |||||||||||||
Operating expenses: | |||||||||||||||||
Selling, General and administrative | 14,846 | 11,693 | 1,828 | 1,325 | |||||||||||||
Income from operations | 12,652 | (3,171 | ) | 14,080 | 1,743 | ||||||||||||
Interest expense (income), net | 9,914 | 9,951 | 120 | (157 | ) | ||||||||||||
Other expense (income) | 441 | 20 | (294 | ) | 715 | ||||||||||||
Income (loss) before provision for income taxes | 2,297 | (13,142 | ) | 14,254 | 1,185 | ||||||||||||
Provision for income taxes | 1,100 | (6,465 | ) | 6,995 | 570 | ||||||||||||
Net income (loss) | $ | 1,197 | $ | (6,677 | ) | $ | 7,259 | $ | 615 | ||||||||
FOR THE SIX MONTHS ENDED DECEMBER 31, 1999
Non- | |||||||||||||||||
Total | Issuer | Guarantors | Guarantors | ||||||||||||||
Net sales | $ | 212,307 | $ | 72,659 | $ | 119,284 | $ | 20,364 | |||||||||
Cost of sales | 155,804 | 51,402 | 90,285 | 14,117 | |||||||||||||
Gross profit | 56,503 | 21,257 | 28,999 | 6,247 | |||||||||||||
Operating expenses: | |||||||||||||||||
Selling, General and administrative | 28,988 | 20,758 | 5,782 | 2,448 | |||||||||||||
Income from operations | 27,515 | 499 | 23,217 | 3,799 | |||||||||||||
Interest expense (income), net | 19,539 | 19,655 | 36 | (152 | ) | ||||||||||||
Other expense (income) | 623 | 114 | (580 | ) | 1,089 | ||||||||||||
Income (loss) before provision for income taxes | 7,353 | (19,270 | ) | 23,761 | 2,862 | ||||||||||||
Provision for income taxes | 3,600 | (9,500 | ) | 11,700 | 1,400 | ||||||||||||
Net income (loss) | $ | 3,753 | $ | (9,770 | ) | $ | 12,061 | $ | 1,462 | ||||||||
10
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Continued)
CONDENSED CONSOLIDATED BALANCE SHEET AT DECEMBER 31, 1999
Non- | |||||||||||||||||||||
Total | Eliminations | Issuer | Guarantors | Guarantors | |||||||||||||||||
Current assets | $ | 189,041 | $ | | $ | 39,522 | $ | 119,192 | $ | 30,327 | |||||||||||
Property, plant and equipment, net | 132,498 | | 40,148 | 77,654 | 14,696 | ||||||||||||||||
Intangible assets | 200,945 | | 45,395 | 154,147 | 1,403 | ||||||||||||||||
Investment in subsidiaries | | (380,690 | ) | 380,690 | | | |||||||||||||||
Deferred financing costs, net | 18,112 | | 17,713 | 170 | 229 | ||||||||||||||||
Other long-term assets | 5,124 | (116,796 | ) | 67,647 | 42,926 | 11,347 | |||||||||||||||
Total assets | $ | 545,720 | $ | (497,486 | ) | $ | 591,115 | $ | 394,089 | $ | 58,002 | ||||||||||
Current liabilities | $ | 75,302 | $ | | $ | 26,185 | $ | 35,784 | $ | 13,333 | |||||||||||
Long-term debt | 411,474 | | 405,463 | | 6,011 | ||||||||||||||||
Other long-term liabilities | 4,900 | (116,796 | ) | 98,021 | 4,487 | 19,188 | |||||||||||||||
Total liabilities | 491,676 | (116,796 | ) | 529,669 | 40,271 | 38,532 | |||||||||||||||
Additional paid-in capital | 41,075 | (312,408 | ) | 41,076 | 296,766 | 15,641 | |||||||||||||||
Retained earnings | 16,342 | (68,282 | ) | 20,370 | 57,052 | 7,202 | |||||||||||||||
Cumulative currency translation adjustment | (3,373) | | | | (3,373 | ) | |||||||||||||||
Total equity | 54,044 | (380,690 | ) | 61,446 | 353,818 | 19,470 | |||||||||||||||
Total liabilities and equity | $ | 545,720 | $ | (497,486 | ) | $ | 591,115 | $ | 394,089 | $ | 58,002 | ||||||||||
CONDENSED CONSOLIDATED BALANCE SHEET AT JULY 2, 1999
Non- | |||||||||||||||||||||
Total | Eliminations | Issuer | Guarantors | Guarantors | |||||||||||||||||
Current assets | $ | 191,706 | $ | | $ | 45,967 | $ | 117,689 | $ | 28,050 | |||||||||||
Property, plant and equipment, net | 136,953 | | 44,507 | 77,132 | 15,314 | ||||||||||||||||
Intangible assets | 206,140 | | 68,073 | 136,639 | 1,428 | ||||||||||||||||
Investment in subsidiaries | | (367,167 | ) | 367,167 | | | |||||||||||||||
Deferred financing costs, net | 19,358 | | 19,257 | (128 | ) | 229 | |||||||||||||||
Deferred taxes | 1,346 | | 1,346 | | | ||||||||||||||||
Other long-term assets | 3,933 | (132,685 | ) | 89,222 | 36,046 | 11,350 | |||||||||||||||
Total assets | $ | 559,436 | $ | (499,852 | ) | $ | 635,539 | $ | 367,378 | $ | 56,371 | ||||||||||
Current liabilities | $ | 90,261 | $ | | $ | 52,551 | $ | 26,868 | $ | 10,842 | |||||||||||
Long-term debt | 410,646 | | 404,288 | | 6,358 | ||||||||||||||||
Other long-term liabilities | 6,232 | (132,685 | ) | 119,759 | | 19,158 | |||||||||||||||
Total liabilities | 507,139 | (132,685 | ) | 576,598 | 26,868 | 36,358 | |||||||||||||||
Additional paid-in capital | 41,075 | (312,408 | ) | 41,095 | 296,747 | 15,641 | |||||||||||||||
Retained earnings | 12,590 | (54,759 | ) | 17,846 | 43,763 | 5,740 | |||||||||||||||
Cumulative currency translation adjustment | (1,368 | ) | | | | (1,368 | ) | ||||||||||||||
Total equity | 52,297 | (367,167 | ) | 58,941 | 340,510 | 20,013 | |||||||||||||||
Total liabilities and equity | $ | 559,436 | $ | (499,852 | ) | $ | 635,539 | $ | 367,378 | $ | 56,371 | ||||||||||
11
Item 2: Managements Discussion and Analysis of Financial Condition and Results of Operations
Second quarter of Fiscal 2000 Compared with the second quarter of Fiscal 1999
Net Sales increased to $102.4 million for the three months ended December 31, 1999 from $94.0 million for the three months ended January 1, 1999. This represents an increase of $8.4 million or 8.9%. The increase in sales over the same period in the prior year is due primarily to the acquisition of Tri-Seal International in January 1999 and Natvar in April 1999, increases in selling prices, and growth in the Healthcare Packaging, Products, and Materials and the Consumer Packaging and Products segments, offset by factors related to the restructuring of acquired operations. These factors include primarily the elimination in fiscal 2000 of low-margin sales in certain acquired businesses, and to a lesser extent the elimination of sales to Natvar, which became intercompany transfers after the acquisition. The level of growth for the second quarter of fiscal 2000 may not be indicative of future operations.
Cost of Sales increased to $74.9 million for the three months ended December 31, 1999 from $69.1 million for the three months ended January 1, 1999. Expressed as a percentage of net sales, cost of sales decreased to 73.1% for the three months ended December 31, 1999 from 73.5% for the three months ended January 1, 1999. The decrease in cost of sales as a percentage of net sales was due primarily to efficiencies achieved in operations acquired with the purchase of PureTec, partially offset by higher raw material costs.
Gross Profit as a result, increased to $27.5 million or 26.9% of net sales for the three months ended December 31, 1999, from $24.9 million or 26.5% of net sales for the three months ended January 1, 1999.
Selling, general and administrative expense increased slightly to $14.8 million or 14.5% of net sales for the three months ended December 31, 1999, from $14.6 million or 15.5% of net sales for the three months ended January 1, 1999. The decrease in selling, general and administrative expense as a percentage of net sales was due primarily to higher net sales for the current quarter.
Operating profit increased to $12.7 million or 12.4% of net sales for the three months ended December 31, 1999, from $10.3 million or 11.0% of net sales for the three months ended January 1, 1999, for the reasons discussed above.
Interest expense increased to $9.9 million or 9.7% of net sales for the three months ended December 31, 1999, from $9.4 million or 10.0% of net sales for the same period in the prior year. This is due primarily to an increase in the revolving line of credit incurred to acquire Tri-Seal International and Natvar, as well as higher interest rates.
Provision for income taxes increased to $1.1 million or 1.1% of net sales for the three months ended December 31, 1999, from $0.3 million or 0.3% of net sales for the same period in the prior year. The Companys effective tax rate was 47.9% for the three months ended December 31, 1999 compared to 36.8% for the same period in the prior year. The increase in the effective tax rate between periods is due primarily to adjustments made in the prior years quarter that were intended to more accurately reflect the annualized rate of income tax.
Net income increased to $1.2 million or 1.2% of net sales for the three months ended December 31, 1999, from $0.5 million or 0.5% of net sales for the same period in the prior year, for the reasons discussed above.
First six months of Fiscal 2000 Compared with the first six months of Fiscal 1999
Net Sales increased to $212.3 million for the six months ended December 31, 1999 from $202.1 million for the six months ended January 1, 1999. This represents an increase of $10.2 million or 5.1%. The increase in sales over the same period in the prior year is due primarily to the acquisition of Tri-Seal International in January 1999 and Natvar in April 1999, increases in selling prices, and growth in the Healthcare Packaging, Products, and Materials and the Consumer Packaging and Products segments, offset by factors related to the restructuring of acquired operations. These factors include primarily the elimination in fiscal 2000 of low-margin sales in certain acquired businesses, and to a lesser extent the elimination of sales to Natvar, which became intercompany transfers after the acquisition. The level of growth for the first six months of fiscal 2000 may not be indicative of future operations.
12
Cost of Sales increased to $155.8 million for the six months ended December 31, 1999 from $150.1 million for the six months ended January 1, 1999. Expressed as a percentage of net sales, cost of sales decreased to 73.4% for the six months ended December 31, 1999 from 74.3% for the six months ended January 1, 1999. The decrease in cost of sales as a percentage of net sales was due primarily to efficiencies achieved in operations acquired with the purchase of PureTec, partially offset by higher raw material costs.
Gross Profit as a result, increased to $56.5 million or 26.6% of net sales for the six months ended December 31, 1999, from $52.0 million or 25.7% of net sales for the six months ended January 1, 1999.
Selling, general and administrative expense increased slightly to $29.0 million or 13.7% of net sales for the six months ended December 31, 1999, from $28.5 million or 14.1% of net sales for the six months ended January 1, 1999. The decrease in selling, general and administrative expense as a percentage of net sales was due primarily to higher net sales for the current period.
Operating profit increased to $27.5 million or 13.0% of net sales for the six months ended December 31, 1999, from $23.5 million or 11.6% of net sales for the six months ended January 1, 1999, for the reasons discussed above.
Interest expense increased to $19.5 million or 9.2% of net sales for the six months ended December 31, 1999, from $19.0 million or 9.4% of net sales for the same period in the prior year. This is due primarily to an increase in the revolving line of credit incurred to acquire Tri-Seal International and Natvar, as well as higher interest rates.
Provision for income taxes increased to $3.6 million or 1.7% of net sales for the six months ended December 31, 1999, from $1.9 million or 0.9% of net sales for the same period in the prior year. The Companys effective tax rate was 49.0% for the six months ended December 31, 1999 compared to 48.1% for the same period in the prior year.
Net income increased to $3.8 million or 1.8% of net sales for the six months ended December 31, 1999, from $2.0 million or 1.0% of net sales for the same period in the prior year, for the reasons discussed above.
Liquidity and Capital Resources
For the six months ended December 31, 1999, net cash provided by operating activities was $6.3 million compared to $5.8 million for the same period in the prior year. This was due primarily to an increase in net income. Various year-over-year changes in operating assets and liabilities are due to generally offsetting timing differences.
Working capital at December 31, 1999 was $113.7 million compared to $101.4 million at July 2, 1999. The increase in working capital was due primarily to decreases in accrued expenses. Offsetting changes in accounts receivable and inventories are normal seasonal differences related primarily to the Consumer Packaging and Products segment.
As of December 31, 1999 the Company had an outstanding balance of $26.0 million under the $90 million revolving credit line of the existing credit facility. This is an increase of $4.0 million from the outstanding balance as of July 2, 1999, due primarily to normal seasonal requirements of the Consumer Packaging and Products segment.
The Companys capital expenditures for the six months ended December 31, 1999 and January 1, 1999 were $6.2 million, and $4.8 million respectively. Management expects that annual capital expenditures will increase from historical levels during the next few years as the Company makes improvements in the recently acquired operations.
Apart from acquisitions, the Companys principal uses of cash for the next several years will be debt service, capital expenditures and working capital requirements. Management believes that cash generated from operations plus funds from the credit facility will be sufficient to meet the Companys expected debt service requirements, planned capital expenditures, and operating needs. However, there can be no assurance that sufficient funds will be available from operations or borrowings under the credit facility to meet the
13
Item 3: Quantitative and Qualitative Disclosures About Market Risk
The Company is subject to market risk inherent in certain debt instruments. At December 31, 1999, the principal amount of the Companys aggregate outstanding variable rate indebtedness was $136.0 million. A hypothetical 10% adverse change in interest rates would have an annualized unfavorable impact of approximately $0.6 million on the Companys after-tax earnings and cash flows, assuming the Companys current effective tax rate and assuming no change in the principal amount. Conversely, a reduction in interest rates would favorably impact the Companys after-tax earnings and cash flows, in a similar proportion.
14
PART II.
OTHER INFORMATION
Item 1. Legal Proceedings
The Company is party to certain litigation in the ordinary course of business, none of which the Company believes is likely to have a material adverse effect on its consolidated financial position or results of operations.
Item 2. Changes in Securities
None
Item 3. Defaults Upon Senior Securities
None
Item 4. Submission of Matters to a Vote of Securities holders
Not applicable
Item 5. Other Information
In order to provide liquidity to certain investors in the Companys sole stockholder, the Company has decided to pursue a recapitalization of the Company. The Company currently anticipates completing the recapitalization before the end of fiscal year 2000. The recapitalization is subject to various contingencies, including the availability of sufficient debt and equity financing on terms acceptable to the Company and certain of its principal investors, and approval by various investors in the Company. Although there can be no assurance that the proposed recapitalization will be consummated at all or without delay, the Company currently contemplates that substantially all of the Companys current outstanding indebtedness will be refinanced as part of the proposed recapitalization of the Company.
Item 6. Exhibits and Reports on Form 8-K
(a) Exhibit 27 Financial Data Schedule
(b) Reports on Form 8-K
None
15
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
TEKNI-PLEX, INC. |
February 9, 2000
By: | /s/ F. PATRICK SMITH |
_______________________________________ F. Patrick Smith |
|
Chairman of the Board and | |
Chief Executive Officer |
By: | /s/ KENNETH W.R. BAKER |
_______________________________________ Kenneth W. R. Baker |
|
President and Chief Operating Officer | |
and Principal Accounting and Financial Officer |
16
|